1. David Baltimore, Mark P Boldin, Ryan M O’Connell, Dinesh S Rao, Konstantin D Taganov, 2008. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 9 (8): 839-45.
2. Antoaneta Belcheva, 2017. MicroRNAs at the epicenter of intestinal homeostasis. Bioessays 39, 3, 1600200.
3. Rajesha Rupaimoole, Frank J. Slack, 2017. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discovery 16, 203-222.
4. Jean-Malo Couzigou, Dominique Lauressergues, Olivier Andre, Caroline Gutjahr, Bruno Guillotin, Guillaume Be´ card, Jean-Philippe Combier, 2017. Positive Gene Regulation by a Natural Protective miRNA Enables Arbuscular Mycorrhizal Symbiosis. Cell Host & Microbe 21, 106–112.
5. Peng Xu, Qian Wu, Jian Yu, Yongsheng Rao, Zheng Kou, Gang Fang, Xiaolong Shi, Wenbin Liu, Henry Han, 2020. A systematic way to infer the regulation relations of miRNAs on target genes and critical miRNAs in cancers. Front. Genet. 11: 278.
6. Peck BC, Sincavage J, Feinstein S, Mah AT, et al. 2016. MiR-30 family controls proliferation and differentiation of intestinal epithelial cell models by directing a broad gene expression program that includes SOX9 and the ubiquitin ligase pathway. J Biol Chem 291: 15975– 84.
7. Nguyen HT, Dalmasso G, Yan Y, Laroui H, et al. 2010. MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. J Biol Chem 285: 1479– 89.
8. Yan Y, Vasudevan S, Nguyen HT, Merlin D. 2008. Intestinal epithelial CD98: an oligomeric and multifunctional protein. Biochim Biophys Acta 1780: 1087– 92.
9. Lee J, Park EJ, Yuki Y, Ahmad S, et al. 2015. Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis. Sci Rep 5: 18174.
10. Chen Y, Xiao Y, Ge W, Zhou K, et al. 2013. miR-200b inhibits TGF-beta1- induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells. Cell Death Dis 4: e541.
11. Liao Y, Zhang M, Lonnerdal B. 2013. Growth factor TGF-beta induces intestinal epithelial cell (IEC-6) differentiation: miR-146b as a regulatory component in the negative feedback loop. Genes Nutr 8: 69– 78.
12. Wharton K, Derynck R. 2009. TGFbeta family signaling: novel insights in development and disease. Development 136: 3691– 7.
13. Liu S, da Cunha AP, Rezende RM, Cialic R, et al. 2016. The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe 19: 32– 43.
14. Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA. 2015. The fusion of two worlds: non-coding RNAs and extracellular vesicles-diagnostic and therapeutic implications (Review). Int J Oncol 46: 17– 27.
15. Larsson E, Tremaroli V, Lee YS, Koren O, et al. 2012. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 61: 1124– 31.
16. Camp JG, Frank CL, Lickwar CR, Guturu H, et al. 2014. Microbiota modulate transcription in the intestinal epithelium without remodeling the accessible chromatin landscape. Genome Res 24: 1504– 16.
17. Dalmasso G, Nguyen HT, Yan Y, Laroui H, et al. 2011. Microbiota modulate host gene expression via microRNAs. PLoS ONE 6: e19293.
18. Christina Loennroth, Marianne Andersson, Annette Arvidsson, Svante Nordgren, Hans Brevinge, Kristina Lagerstedt and Kent Lundholm, 2008. Preoperative treatment with a non-steroidal anti-inflammatory drug (NSAID) increases tumor tissue infiltration of seemingly activated immune cells in colorectal cancer. Cancer Immunity 8: 5.
19. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
20. Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843–854 (1993).
21. Reinhart, B. J. et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901–906 (2000).
22. Pasquinelli, A. E. et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86–89 (2000).
23. Esteller, M. Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861–874 (2011).
24. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
25. Roush, S. & Slack, F. J. The let-7 family of microRNAs. Trends Cell Biol. 18, 505–516 (2008).
26. Iorio, M. V. & Croce, C. M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143–159 (2012).
27. Tili, E., Michaille, J. J. & Croce, C. M. MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol. Rev. 253, 167–184 (2013).
28. Rupaimoole, R., Calin, G. A., Lopez-Berestein, G. & Sood, A. K. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 6, 235–246 (2016).
29. Gurha, P. MicroRNAs in cardiovascular disease. Curr. Opin. Cardiol. 31, 249– 254 (2016).
30. Worringer, K. A. et al. The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes. Cell Stem Cell 14, 40–52 (2014).
31. Jana Merhautova, Tana Machackova, Vychytilova-Faltejskova et al 2017. MiR- 215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9. Oncogenesis 6:399.
32. Shahzad MMK, Felder M, Ludwig K, Van Galder HR, Anderson ML, Kim J, et al. (2018) Trans10,cis12 conjugated linoleic acid inhibits proliferation and migrationof ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src. PLoSONE 13(1): e0189524.
33. Shanthi Sabarimurugan, Sunil Krishnan , Rama Jayaraj. 2020. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Molecular Diagnosis & Therapy (2020) 24:15–30.
34. Xiaodun Li, Sam Kleeman, Sally B.Coburn, 2018. Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett’s Esophagus. Gastroenterology 155: 771-783.
論文の公開元へ
